Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, announced it has signed a distribution a...
The 2018 Global Bio Conference kicked off in Seoul, bringing together biotech regulators and industry experts from around the world to support the growth and overseas expansion of South Korea’s biopharmaceutical businesses.
Pharma Research Products Company Ltd. (PRP) a Korean company engaged in the development of medical esthetic products, secured majority ownership of botulinum toxin type A injection production facility of BioCND.
South Korea’s major biopharmaceutical firm Samsung BioLogics Co., which has been embroiled in an alleged violation of accounting rules, expressed concern over the local financial regulator’s disclosure of sensitive information.
South Korea’s largest biopharmaceutical business association has kickstarted preparations for a support center that will leverage artificial intelligence to help pharmaceutical companies accelerate new drug development processes